View Item 

Show simple item record

ACR appropriateness criteria® nasal cavity and paranasal sinus cancers
dc.contributor.authorSiddiqui, Farzan
dc.contributor.authorSmith, Richard V.
dc.contributor.authorYom, Sue S.
dc.contributor.authorBeitler, Jonathan J.
dc.contributor.authorBusse, Paul M.
dc.contributor.authorCooper, Jay S.
dc.contributor.authorHanna, Ehab Y.
dc.contributor.authorJones, Christopher U.
dc.contributor.authorKoyfman, Shlomo A.
dc.contributor.authorQuon, Harry
dc.contributor.authorRidge, John A.
dc.contributor.authorSaba, Nabil F.
dc.contributor.authorWorden, Francis
dc.contributor.authorYao, Min
dc.contributor.authorSalama, Joseph K.
dc.date.accessioned2017-04-13T20:34:05Z
dc.date.available2018-05-15T21:02:50Zen
dc.date.issued2017-03
dc.identifier.citationSiddiqui, Farzan; Smith, Richard V.; Yom, Sue S.; Beitler, Jonathan J.; Busse, Paul M.; Cooper, Jay S.; Hanna, Ehab Y.; Jones, Christopher U.; Koyfman, Shlomo A.; Quon, Harry; Ridge, John A.; Saba, Nabil F.; Worden, Francis; Yao, Min; Salama, Joseph K. (2017). "ACR appropriateness criteria® nasal cavity and paranasal sinus cancers." Head & Neck 39(3): 407-418.
dc.identifier.issn1043-3074
dc.identifier.issn1097-0347
dc.identifier.urihttps://hdl.handle.net/2027.42/136245
dc.description.abstractThe American College of Radiology (ACR) Appropriateness Criteria are evidence‐based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer‐reviewed journals and the application of well‐established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment. Here, we present the Appropriateness Criteria for cancers arising in the nasal cavity and paranasal sinuses (maxillary, sphenoid, and ethmoid sinuses). This includes clinical presentation, prognostic factors, principles of management, and treatment outcomes. Controversies regarding management of cervical lymph nodes are discussed. Rare and unusual nasal cavity cancers, such as esthesioneuroblastoma and sinonasal undifferentiated carcinomas, are included. © 2016 American College of Radiology. Head Neck, 2016 © 2016 Wiley Periodicals, Inc. Head Neck 39: 407–418, 2017
dc.publisherWiley Periodicals, Inc.
dc.subject.otheresthesioneuroblastoma
dc.subject.otherparanasal sinus cancer
dc.subject.othernasal cavity cancer
dc.subject.otherAppropriateness Criteria
dc.subject.othersinonasal undifferentiated carcinoma
dc.titleACR appropriateness criteria® nasal cavity and paranasal sinus cancers
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOtolaryngology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/136245/1/hed24639.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/136245/2/hed24639_am.pdf
dc.identifier.doi10.1002/hed.24639
dc.identifier.sourceHead & Neck
dc.identifier.citedreferenceHomma A, Oridate N, Suzuki F, et al. Superselective high‐dose cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses: a single institution experience. Cancer 2009; 115: 4705 – 4714.
dc.identifier.citedreferenceZenda S, Kohno R, Kawashima M, et al. Proton beam therapy for unresectable malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys 2011; 81: 1473 – 1478.
dc.identifier.citedreferenceFukumitsu N, Okumura T, Mizumoto M, et al. Outcome of T4 (International Union Against Cancer Staging System, 7th edition) or recurrent nasal cavity and paranasal sinus carcinoma treated with proton beam. Int J Radiat Oncol Biol Phys 2012; 83: 704 – 711.
dc.identifier.citedreferenceChoussy O, Ferron C, Vedrine PO, et al. Adenocarcinoma of ethmoid: a GETTEC retrospective multicenter study of 418 cases. Laryngoscope 2008; 118: 437 – 443.
dc.identifier.citedreferenceVedrine PO, Thariat J, Merrot O, et al. Primary cancer of the sphenoid sinus–a GETTEC study. Head Neck 2009; 31: 388 – 397.
dc.identifier.citedreferenceDeMonte F, Ginsberg LE, Clayman GL. Primary malignant tumors of the sphenoidal sinus. Neurosurgery 2000; 46: 1084 – 1091; discussion 1091–1092.
dc.identifier.citedreferenceBernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004; 350: 1945 – 1952.
dc.identifier.citedreferenceCooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high‐risk squamous‐cell carcinoma of the head and neck. N Engl J Med 2004; 350: 1937 – 1944.
dc.identifier.citedreferenceLee MM, Vokes EE, Rosen A, Witt ME, Weichselbaum RR, Haraf DJ. Multimodality therapy in advanced paranasal sinus carcinoma: superior long‐term results. Cancer J Sci Am 1999; 5: 219 – 223.
dc.identifier.citedreferenceHanna EY, Cardenas AD, DeMonte F, et al. Induction chemotherapy for advanced squamous cell carcinoma of the paranasal sinuses. Arch Otolaryngol Head Neck Surg 2011; 137: 78 – 81.
dc.identifier.citedreferenceLicitra L, Locati LD, Cavina R, et al. Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer. Ann Oncol 2003; 14: 367 – 372.
dc.identifier.citedreferenceHoppe BS, Nelson CJ, Gomez DR, et al. Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities. Int J Radiat Oncol Biol Phys 2008; 72: 763 – 769.
dc.identifier.citedreferenceBernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck 2005; 27: 843 – 850.
dc.identifier.citedreferenceRasch CR, Hauptmann M, Schornagel J, et al. Intra‐arterial versus intravenous chemoradiation for advanced head and neck cancer: results of a randomized phase 3 trial. Cancer 2010; 116: 2159 – 2165.
dc.identifier.citedreferenceSamant S, Robbins KT, Vang M, Wan J, Robertson J. Intra‐arterial cisplatin and concomitant radiation therapy followed by surgery for advanced paranasal sinus cancer. Arch Otolaryngol Head Neck Surg 2004; 130: 948 – 955.
dc.identifier.citedreferenceDirix P, Nuyts S, Geussens Y, et al. Malignancies of the nasal cavity and paranasal sinuses: long‐term outcome with conventional or three‐dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2007; 69: 1042 – 1050.
dc.identifier.citedreferenceGuan X, Wang X, Liu Y, Hu C, Zhu G. Lymph node metastasis in sinonasal squamous cell carcinoma treated with IMRT/3D‐CRT. Oral Oncol 2013; 49: 60 – 65.
dc.identifier.citedreferenceBristol IJ, Ahamad A, Garden AS, et al. Postoperative radiotherapy for maxillary sinus cancer: long‐term outcomes and toxicities of treatment. Int J Radiat Oncol Biol Phys 2007; 68: 719 – 730.
dc.identifier.citedreferenceKadish S, Goodman M, Wang CC. Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 1976; 37: 1571 – 1576.
dc.identifier.citedreferenceChao KS, Kaplan C, Simpson JR, et al. Esthesioneuroblastoma: the impact of treatment modality. Head Neck 2001; 23: 749 – 757.
dc.identifier.citedreferenceDevaiah AK, Andreoli MT. Treatment of esthesioneuroblastoma: a 16‐year meta‐analysis of 361 patients. Laryngoscope 2009; 119: 1412 – 1416.
dc.identifier.citedreferenceSoler ZM, Smith TL. Endoscopic versus open craniofacial resection of esthesioneuroblastoma: what is the evidence? Laryngoscope 2012; 122: 244 – 245.
dc.identifier.citedreferencePolin RS, Sheehan JP, Chenelle AG, et al. The role of preoperative adjuvant treatment in the management of esthesioneuroblastoma: the University of Virginia experience. Neurosurgery 1998; 42: 1029 – 1037.
dc.identifier.citedreferenceSohrabi S, Drabick JJ, Crist H, Goldenberg D, Sheehan JM, Mackley HB. Neoadjuvant concurrent chemoradiation for advanced esthesioneuroblastoma: a case series and review of the literature. J Clin Oncol 2011; 29: e358 – e361.
dc.identifier.citedreferenceOzsahin M, Gruber G, Olszyk O, et al. Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study. Int J Radiat Oncol Biol Phys 2010; 78: 992 – 997.
dc.identifier.citedreferenceMonroe AT, Hinerman RW, Amdur RJ, Morris CG, Mendenhall WM. Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation. Head Neck 2003; 25: 529 – 534.
dc.identifier.citedreferenceZanation AM, Ferlito A, Rinaldo A, et al. When, how and why to treat the neck in patients with esthesioneuroblastoma: a review. Eur Arch Otorhinolaryngol 2010; 267: 1667 – 1671.
dc.identifier.citedreferenceResto VA, Eisele DW, Forastiere A, Zahurak M, Lee DJ, Westra WH. Esthesioneuroblastoma: the Johns Hopkins experience. Head Neck 2000; 22: 550 – 558.
dc.identifier.citedreferenceFrierson HF Jr, Mills SE, Fechner RE, Taxy JB, Levine PA. Sinonasal undifferentiated carcinoma. An aggressive neoplasm derived from Schneiderian epithelium and distinct from olfactory neuroblastoma. Am J Surg Pathol 1986; 10: 771 – 779.
dc.identifier.citedreferenceEjaz A, Wenig BM. Sinonasal undifferentiated carcinoma: clinical and pathologic features and a discussion on classification, cellular differentiation, and differential diagnosis. Adv Anat Pathol 2005; 12: 134 – 143.
dc.identifier.citedreferenceChen AM, Daly ME, El‐Sayed I, et al. Patterns of failure after combined‐modality approaches incorporating radiotherapy for sinonasal undifferentiated carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2008; 70: 338 – 343.
dc.identifier.citedreferenceReiersen DA, Pahilan ME, Devaiah AK. Meta‐analysis of treatment outcomes for sinonasal undifferentiated carcinoma. Otolaryngol Head Neck Surg 2012; 147: 7 – 14.
dc.identifier.citedreferenceTanzler ED, Morris CG, Orlando CA, Werning JW, Mendenhall WM. Management of sinonasal undifferentiated carcinoma. Head Neck 2008; 30: 595 – 599.
dc.identifier.citedreferenceMuir CS, Nectoux J. Descriptive epidemiology of malignant neoplasms of nose, nasal cavities, middle ear and accessory sinuses. Clin Otolaryngol Allied Sci 1980; 5: 195 – 211.
dc.identifier.citedreferenceRoush GC. Epidemiology of cancer of the nose and paranasal sinuses: current concepts. Head Neck Surg 1979; 2: 3 – 11.
dc.identifier.citedreferenceAnsa B, Goodman M, Ward K, et al. Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results data, 1973 to 2009. Cancer 2013; 119: 2602 – 2610.
dc.identifier.citedreferenceGoldenberg D, Golz A, Fradis M, Mârtu D, Netzer A, Joachims HZ. Malignant tumors of the nose and paranasal sinuses: a retrospective review of 291 cases. Ear Nose Throat J 2001; 80: 272 – 277.
dc.identifier.citedreferenceJiang GL, Ang KK, Peters LJ, Wendt CD, Oswald MJ, Goepfert H. Maxillary sinus carcinomas: natural history and results of postoperative radiotherapy. Radiother Oncol 1991; 21: 193 – 200.
dc.identifier.citedreferenceLe QT, Fu KK, Kaplan MJ, Terris DJ, Fee WE, Goffinet DR. Lymph node metastasis in maxillary sinus carcinoma. Int J Radiat Oncol Biol Phys 2000; 46: 541 – 549.
dc.identifier.citedreferenceAllen MW, Schwartz DL, Rana V, et al. Long‐term radiotherapy outcomes for nasal cavity and septal cancers. Int J Radiat Oncol Biol Phys 2008; 71: 401 – 406.
dc.identifier.citedreferenceAng KK, Jiang GL, Frankenthaler RA, et al. Carcinomas of the nasal cavity. Radiother Oncol 1992; 24: 163 – 168.
dc.identifier.citedreferenceDulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T. Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 2001; 92: 3012 – 3029.
dc.identifier.citedreferenceDuprez F, Madani I, Morbee L, et al. IMRT for sinonasal tumors minimizes severe late ocular toxicity and preserves disease control and survival. Int J Radiat Oncol Biol Phys 2012; 83: 252 – 259.
dc.identifier.citedreferenceGuntinas–Lichius O, Kreppel MP, Stuetzer H, Semrau R, Eckel HE, Mueller RP. Single modality and multimodality treatment of nasal and paranasal sinuses cancer: a single institution experience of 229 patients. Eur J Surg Oncol 2007; 33: 222 – 228.
dc.identifier.citedreferenceWiegner EA, Daly ME, Murphy JD, et al. Intensity‐modulated radiotherapy for tumors of the nasal cavity and paranasal sinuses: clinical outcomes and patterns of failure. Int J Radiat Oncol Biol Phys 2012; 83: 243 – 251.
dc.identifier.citedreferenceGanly I, Patel SG, Singh B, et al. Craniofacial resection for malignant paranasal sinus tumors: report of an international collaborative study. Head Neck 2005; 27: 575 – 584.
dc.identifier.citedreferenceKraus DH, Shah JP, Arbit E, Galicich JH, Strong EW. Complications of craniofacial resection for tumors involving the anterior skull base. Head Neck 1994; 16: 307 – 312.
dc.identifier.citedreferenceKomotar RJ, Starke RM, Raper DM, Anand VK, Schwartz TH. Endoscopic endonasal compared with anterior craniofacial and combined cranionasal resection of esthesioneuroblastomas. World Neurosurg 2013; 80: 148 – 159.
dc.identifier.citedreferenceHanna E, DeMonte F, Ibrahim S, Roberts D, Levine N, Kupferman M. Endoscopic resection of sinonasal cancers with and without craniotomy: oncologic results. Arch Otolaryngol Head Neck Surg 2009; 135: 1219 – 1224.
dc.identifier.citedreferenceNicolai P, Battaglia P, Bignami M, et al. Endoscopic surgery for malignant tumors of the sinonasal tract and adjacent skull base: a 10‐year experience. Am J Rhinol 2008; 22: 308 – 316.
dc.identifier.citedreferenceJansen EP, Keus RB, Hilgers FJ, Haas RL, Tan IB, Bartelink H. Does the combination of radiotherapy and debulking surgery favor survival in paranasal sinus carcinoma? Int J Radiat Oncol Biol Phys 2000; 48: 27 – 35.
dc.identifier.citedreferenceMendenhall WM, Amdur RJ, Morris CG, et al. Carcinoma of the nasal cavity and paranasal sinuses. Laryngoscope 2009; 119: 899 – 906.
dc.identifier.citedreferenceResto VA, Chan AW, Deschler DG, Lin DT. Extent of surgery in the management of locally advanced sinonasal malignancies. Head Neck 2008; 30: 222 – 229.
dc.identifier.citedreferenceBlanco AI, Chao KS, Ozyigit G, et al. Carcinoma of paranasal sinuses: long‐term outcomes with radiotherapy. Int J Radiat Oncol Biol Phys 2004; 59: 51 – 58.
dc.identifier.citedreferenceJiang GL, Morrison WH, Garden AS, et al. Ethmoid sinus carcinomas: natural history and treatment results. Radiother Oncol 1998; 49: 21 – 27.
dc.identifier.citedreferenceKarim AB, Kralendonk JH, Njo KH, Tabak JM, Elsenaar WH, van Balen AT. Ethmoid and upper nasal cavity carcinoma: treatment, results and complications. Radiother Oncol 1990; 19: 109 – 120.
dc.identifier.citedreferenceKatz TS, Mendenhall WM, Morris CG, Amdur RJ, Hinerman RW, Villaret DB. Malignant tumors of the nasal cavity and paranasal sinuses. Head Neck 2002; 24: 821 – 829.
dc.identifier.citedreferenceChen AM, Daly ME, Bucci MK, et al. Carcinomas of the paranasal sinuses and nasal cavity treated with radiotherapy at a single institution over five decades: are we making improvement? Int J Radiat Oncol Biol Phys 2007; 69: 141 – 147.
dc.identifier.citedreferenceMadani I, Bonte K, Vakaet L, Boterberg T, De Neve W. Intensity‐modulated radiotherapy for sinonasal tumors: Ghent University Hospital update. Int J Radiat Oncol Biol Phys 2009; 73: 424 – 432.
dc.identifier.citedreferenceTruong MT, Kamat UR, Liebsch NJ, et al. Proton radiation therapy for primary sphenoid sinus malignancies: treatment outcome and prognostic factors. Head Neck 2009; 31: 1297 – 1308.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
hed24639.pdf
Size:
137.6KB
Format:
PDF
View/Open
Name:
hed24639_am.pdf
Size:
412.7KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.